Balchem reports Q3 adjusted EPS $1.13 vs $1.04 last year

Reports Q3 revenue $239.9M, consensus $241.93M. Ted Harris, Chairman, President and CEO of Balchem (BCPC) said, “We delivered strong third quarter financials with solid revenue growth and record earnings from operations and adjusted EBITDA. We continue to see excellent performance in our Human Nutrition and Health and Specialty Products segments, both delivering strong sales and earnings growth.”